Second autologous transplant as salvage therapy in multiple myeloma
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Second autologous transplant as salvage therapy in multiple myeloma
Authors
Keywords
-
Journal
BRITISH JOURNAL OF HAEMATOLOGY
Volume 163, Issue 5, Pages 565-572
Publisher
Wiley
Online
2013-10-12
DOI
10.1111/bjh.12579
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Salvage autologous stem cell transplantation for multiple myeloma relapsing or progressing after up-front autologous transplantation
- (2013) Holger W. Auner et al. LEUKEMIA & LYMPHOMA
- Lenalidomide in multiple myeloma: Current status and future potential
- (2012) Hang Quach et al. AMERICAN JOURNAL OF HEMATOLOGY
- Autologous Stem Cell Transplantation: An Effective Salvage Therapy in Multiple Myeloma
- (2012) Emilie Lemieux et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Proteasome inhibitors in multiple myeloma: 10 years later
- (2012) P. Moreau et al. BLOOD
- Second auto-SCT for treatment of relapsed multiple myeloma
- (2012) W I Gonsalves et al. BONE MARROW TRANSPLANTATION
- Relapsed multiple myeloma: who benefits from salvage autografts?
- (2012) A. W. S. Chow et al. INTERNAL MEDICINE JOURNAL
- Superiority of the Triple Combination of Bortezomib-Thalidomide-Dexamethasone Over the Dual Combination of Thalidomide-Dexamethasone in Patients With Multiple Myeloma Progressing or Relapsing After Autologous Transplantation: The MMVAR/IFM 2005-04 Randomized Phase III Trial From the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation
- (2012) Laurent Garderet et al. JOURNAL OF CLINICAL ONCOLOGY
- Optimizing therapy for transplant-eligible patients with newly diagnosed multiple myeloma
- (2012) Philippe Moreau et al. LEUKEMIA RESEARCH
- Factors Influencing the Outcome of a Second Autologous Stem Cell Transplant (ASCT) in Relapsed Multiple Myeloma: A Study from the British Society of Blood and Marrow Transplantation Registry
- (2011) Gordon Cook et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Second Autologous Stem Cell Transplantation as Salvage Therapy for Multiple Myeloma: Impact on Progression-Free and Overall Survival
- (2011) Victor H. Jimenez-Zepeda et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Guidelines for the diagnosis and management of multiple myeloma 2011
- (2011) Jennifer M. Bird et al. BRITISH JOURNAL OF HAEMATOLOGY
- Durable remission with salvage second autotransplants in patients with multiple myeloma
- (2011) Nina Shah et al. CANCER
- Melphalan 100 mg/m2 with stem cell support as first relapse treatment is safe and effective for myeloma patients with long remission after autologous stem cell transplantation
- (2011) Cecilie Blimark et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Can multiple myeloma become a curable disease?
- (2011) J. F. San-Miguel et al. HAEMATOLOGICA
- Current Trends in Autologous Stem-Cell Transplantation for Myeloma in the Era of Novel Therapies
- (2011) Philippe Moreau et al. JOURNAL OF CLINICAL ONCOLOGY
- Predictive factors for successful salvage high-dose therapy in patients with multiple myeloma relapsing after autologous blood stem cell transplantation
- (2011) Roland Fenk et al. LEUKEMIA & LYMPHOMA
- Multiple myeloma: 2011 update on diagnosis, risk-stratification, and management
- (2010) S. Vincent Rajkumar AMERICAN JOURNAL OF HEMATOLOGY
- International Myeloma Working Group Consensus Statement Regarding the Current Status of Allogeneic Stem-Cell Transplantation for Multiple Myeloma
- (2010) Henk Lokhorst et al. JOURNAL OF CLINICAL ONCOLOGY
- Survival and Years of Life Lost in Different Age Cohorts of Patients With Multiple Myeloma
- (2010) Heinz Ludwig et al. JOURNAL OF CLINICAL ONCOLOGY
- Salvage treatment with upfront melphalan 100 mg/m2 and consolidation with novel drugs for fulminant progression of multiple myeloma
- (2009) Marta Krejci et al. ANNALS OF HEMATOLOGY
- Bortezomib plus dexamethasone is highly effective in relapsed and refractory myeloma patients but responses are short-lived
- (2009) Alessandro Corso et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Achievement of at Least Very Good Partial Response Is a Simple and Robust Prognostic Factor in Patients With Multiple Myeloma Treated With High-Dose Therapy: Long-Term Analysis of the IFM 99-02 and 99-04 Trials
- (2009) Jean-Luc Harousseau et al. JOURNAL OF CLINICAL ONCOLOGY
- Patterns of Improved Survival in Patients With Multiple Myeloma in the Twenty-First Century: A Population-Based Study
- (2009) Ingemar Turesson et al. JOURNAL OF CLINICAL ONCOLOGY
- Toxicity of a second autologous peripheral blood stem cell transplant in patients with relapsed or recurrent multiple myeloma
- (2009) Julianna Aleathea Burzynski et al. LEUKEMIA & LYMPHOMA
- Second auto-SCT is safe and effective salvage therapy for relapsed multiple myeloma
- (2008) R L Olin et al. BONE MARROW TRANSPLANTATION
- Treatment of relapsed and refractory myeloma
- (2008) Donna E. Reece et al. LEUKEMIA & LYMPHOMA
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started